The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
Author(s) -
Spyridon Deftereos,
Gerasimos Siasos,
Γεώργιος Γιαννόπουλος,
Dimitrios A. Vrachatis,
Christos Angelidis,
Sotiria G. Giotaki,
Panagiotis Gargalianos,
Helen Giamarellou,
Charalampos Gogos,
Georgios Daikos,
Marios Lazanas,
Παγώνα Λάγιου,
Georgios Saroglou,
Nikolaos V. Sipsas,
Sotirios Tsiodras,
Dimitrios Chatzigeorgiou,
Nikolaos Moussas,
Αναστασία Κοτανίδου,
Νikolaos Koulouris,
Evangelos Oikonomou,
Andreas Kaoukis,
Charalampos Kossyvakis,
Konstantinos Raisakis,
Katerina Fountoulaki,
Mihalis Comis,
Dimitris Tsiachris,
Eleni Sarri,
Andreas Theodorakis,
Luis MartínezDolz,
Jorge Sanz Sánchez,
Bernhard Reimers,
Giulio Stefanini,
Michael Cleman,
Dimitrios Filippou,
Christoforos Olympios,
Vlasios Pyrgakis,
John Goudevenos,
George Hahalis,
Theofilos M. Kolettis,
Efstathios K. Iliodromitis,
Dimitrios Tousoulis,
Christodoulos Stefanadis
Publication year - 2020
Publication title -
hellenic journal of cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.513
H-Index - 19
eISSN - 2241-5955
pISSN - 1109-9666
DOI - 10.1016/j.hjc.2020.03.002
Subject(s) - medicine , colchicine , covid-19 , anosmia , randomized controlled trial , clinical trial , intensive care medicine , disease , infectious disease (medical specialty)
GRECCO-19 trial aims to identify whether colchicine may positively intervene in the clinical course of COVID-19. (The study has been submitted to clinicaltrials.gov on March 26, 2020).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom